Showing results (421-430 of 456) with videos related to

Sort By:
Pageof 46
Hepatology (Baltimore, Md.)|June 25, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosisJie Li, Liang Xu, Fajuan Rui, et al.
The New England Journal of Medicine|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus InfectionJinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Journal of Gastroenterology and Hepatology|March 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational studyTyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Alimentary Pharmacology & Therapeutics|January 4, 2024
Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic responseJung Eun Park, Vy H Nguyen, Pei-Chien Tsai, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2023
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal StudyAngela Chau, Ming-Lun Yeh, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|October 27, 2023
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogsTyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Hepatology International|August 8, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, et al.
American Journal of Cancer Research|August 15, 2022
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort studyHung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, et al.
The American Journal of Gastroenterology|March 30, 2020
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Chung-Feng Huang, Hsueh-Chou Lai, Chi-Yi Chen, et al.
Pageof 46